<SEC-DOCUMENT>0000929638-23-000414-index.html : 20230213 <SEC-HEADER>0000929638-23-000414.hdr.sgml : 20230213 <ACCEPTANCE-DATETIME>20230213163059 ACCESSION NUMBER: 0000929638-23-000414 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20230213 DATE AS OF CHANGE: 20230213 GROUP MEMBERS: JEFF EASTON GROUP MEMBERS: LIND GLOBAL MACRO FUND LP GROUP MEMBERS: LIND GLOBAL PARTNERS II LLC GROUP MEMBERS: LIND GLOBAL PARTNERS LLC SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Vallon Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001824293 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 824369909 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-92206 FILM NUMBER: 23618995 BUSINESS ADDRESS: STREET 1: TWO LOGAN SQUARE STREET 2: 100 N. 18TH STREET, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 BUSINESS PHONE: (267) 607-8255 MAIL ADDRESS: STREET 1: TWO LOGAN SQUARE STREET 2: 100 N. 18TH STREET, SUITE 300 CITY: PHILADELPHIA STATE: PA ZIP: 19103 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Lind Global Fund II LP CENTRAL INDEX KEY: 0001871665 IRS NUMBER: 863914253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 444 MADISON AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 646-701-7428 MAIL ADDRESS: STREET 1: 444 MADISON AVENUE STREET 2: 41ST FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 </SEC-HEADER> <DOCUMENT> <TYPE>SC 13G/A <SEQUENCE>1 <FILENAME>sc13ga.htm <DESCRIPTION>AMENDMENT NO. 1 <TEXT> Document 1 - file: sc13ga.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>exhibit99-1.htm <DESCRIPTION>JOINT FILING AGREEMENT BY AND AMONG THE REPORTING PERSONS <TEXT> Document 2 - file: exhibit99-1.htm
</DOCUMENT> </SEC-DOCUMENT>